ClinicalTrials.gg

Metsera clinical trials

Acquired by Pfizer, Nov 13, 2025 · source ↗

The registry lists 1 studies whose lead sponsor is Metsera. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 28, 2026.

Before and after it joined Pfizer

First submitted before Metsera became part of Pfizer
1
First submitted after Metsera became part of Pfizer
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Metsera’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

All 1 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed1100%

Phase

  • Phase 21
  • Phase 11

Where

  • United States1

Over the years

  1. 124
  2. 25
  3. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Metsera, a wholly owned subsidiary of Pfizer1 study

Something wrong with this grouping? Tell us on the Pfizer page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Pfizer studies →